menu search

IDXX / IDEXX (IDXX) CAG Sales Gain Traction, FX Headwind Persists

IDEXX (IDXX) CAG Sales Gain Traction, FX Headwind Persists
IDEXX (IDXX) has been witnessing continued high CAG Diagnostics recurring revenue growth across major regions with solid gains across its key in-clinic platforms. Read More
Posted: Apr 12 2022, 12:02
Author Name: Zacks Investment Research
Views: 111665

IDXX News  

Compared to Estimates, Idexx (IDXX) Q3 Earnings: A Look at Key Metrics

By Zacks Investment Research
November 1, 2023

Compared to Estimates, Idexx (IDXX) Q3 Earnings: A Look at Key Metrics

Although the revenue and EPS for Idexx (IDXX) give a sense of how its business performed in the quarter ended September 2023, it might be worth consid more_horizontal

IDEXX Laboratories (IDXX) to Post Q3 Earnings: What's in Store?

By Zacks Investment Research
October 23, 2023

IDEXX Laboratories (IDXX) to Post Q3 Earnings: What's in Store?

IDEXX Laboratories' (IDXX) third-quarter 2023 results are expected to reflect an impressive performance of the CAG segment. more_horizontal

Here's Why You Should Hold on to IDEXX (IDXX) Stock Right Now

By Zacks Investment Research
September 19, 2023

Here's Why You Should Hold on to IDEXX (IDXX) Stock Right Now

Investors are optimistic about IDEXX (IDXX) on solid premium instrument placements and upbeat guidance. more_horizontal

Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now

By Zacks Investment Research
August 18, 2023

Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now

Investors continue to be optimistic about IDEXX (IDXX) due to the CAG business and the company's execution of its growth strategy. more_horizontal

Atlantic Equities Downgrades Idexx Laboratories

By 24/7 Wall Street
August 2, 2023

Atlantic Equities Downgrades Idexx Laboratories

Fintel reports that on August 2, 2023, Atlantic Equities downgraded their outlook for Idexx Laboratories (NASDAQ:IDXX) from Overweight to Neutral. more_horizontal

IDEXX Laboratories, Inc. (IDXX) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 1, 2023

IDEXX Laboratories, Inc. (IDXX) Q2 2023 Earnings Call Transcript

IDEXX Laboratories, Inc. (NASDAQ:IDXX ) Q2 2023 Earnings Conference Call August 1, 2023 8:30 AM ET Company Participants Jay Mazelsky - President and C more_horizontal

IDEXX (IDXX) Q2 Earnings and Revenues Beat Estimates, View Up

By Zacks Investment Research
August 1, 2023

IDEXX (IDXX) Q2 Earnings and Revenues Beat Estimates, View Up

IDEXX (IDXX) delivers better-than-expected earnings and revenues in the second quarter of 2023, backed by CAG Diagnostics' recurring revenue growth. more_horizontal

Idexx (IDXX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

By Zacks Investment Research
August 1, 2023

Idexx (IDXX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Idexx (IDXX) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare more_horizontal


Search within

Pages Search Results: